Plasma erlotinib concentrations in elderly versus younger patients with advanced or metastatic non-small cell lung cancer
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2015
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- 15 Jul 2015 New trial record
- 02 Jun 2015 Consecutive patients treated with erlotinib were enrolled between 2010 and 2014, according to the ASCO abstract.
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.